Evidence map›Paper›PMID 40949969›Full record

ArticlebioRxiv : the preprint server for biology2025

Renaldo Sutanto, Jaimin Rana, Billy Tsai, Shyamal Mosalaganti

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renaldo SutantoLife Sciences Institute, University of Michigan, Ann Arbor, MI 48108, United States.
Jaimin RanaLife Sciences Institute, University of Michigan, Ann Arbor, MI 48108, United States.
Billy TsaiDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, United States.
Shyamal MosalagantiLife Sciences Institute, University of Michigan, Ann Arbor, MI 48108, United States.ORCID 0000-0002-5934-687X

Funding

Retrograde TGN/Golgi transport and nuclear targeting of HPV during entryR01AI150897 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Daniel C. Dimaio, Billy Tsai · 2020 to 2026
$3.5M
In-situ architecture of membrane contact sites mediating organelle fissionDP2GM150019 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOSALAGANTI, SHYAMAL · 2022 to 2025
$2.3M
Compute Cluster for in vitro and in situ Analysis of Molecular MachinesS10OD030275 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OHI, MELANIE DIANE · 2021 to 2021
$600k
NIAID NIH HHS R01 AI150897NIGMS NIH HHS DP2 GM150019NIH HHS S10 OD030275
6 · The paper itself

Abstract

Human papillomavirus (HPV) causes 4.5% of all human cancers, although a complete cellular basis of infection remains unclear. The mechanisms of virus disassembly and transport are particularly enigmatic. Here, we use

Identifiers

PMID40949969
PMCPMC12424790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.